Contents
Contents
Blue Cross Blue Shield antitrust territorial restrictions were central to a $2.67 billion subscriber settlement and a separate $2.8 billion provider settlement over alleged limits on competition among Blue Plans. The cases concern different sides of the same business: buying health coverage and getting paid to deliver care. For someone inside a Plan or a provider’s contracting department, the telling detail may be a contract another Plan would not discuss, a rate it could not offer or a payment the local Plan took back.
The defendants were the Blue Cross and Blue Shield Association and the settling Member Plans. The subscriber claims challenged territorial and business restrictions among those Plans. The provider claims challenged alleged division of service areas and coordination of provider prices.
Agreements among competitors to divide territories can violate the Sherman Act. The provider allegations here concerned an agreement about who could sell coverage and who could buy healthcare services in each area.
The provider complaint alleged that independent Blue companies divided the country into exclusive service areas in which only one Blue could sell insurance, administer employee benefit plans or contract with healthcare providers. A territory therefore reached beyond the name on an insurance card. Under the alleged arrangement, it also determined which Plan a hospital or medical practice could bargain with.
The complaint’s account of the licensing rules also described restrictions on business under other brands. Each Member Plan allegedly agreed to derive at least 80% of its annual revenue within its service area from Blue-branded services, excluding Medicare and Medicaid. A separate requirement allegedly put at least two-thirds of revenue from inside and outside the service area under the Blue brands, with the same exclusions.
That second restriction explains why simply developing another brand was part of the dispute. The complaint alleged that the revenue requirements limited each Plan’s ability to grow non-Blue business that could compete with other Blues. The territorial rule restricted competition under the shared names. The revenue rules allegedly constrained the alternative.
The association’s role also appears in decisions about particular contracts. In the complaint’s account, it could communicate refusals on behalf of several Plans and stop an arrangement that would give subscribers access to a disputed provider. The companies made the contracts, but the alleged restrictions reached across company lines.
The complaint alleged that some Plans agreed to stay out even where the written licensing arrangements allowed them to compete. Its border-county example makes the difference concrete:
For example, under the Licensing Agreements, each Blue is allowed to contract one county into a contiguous or adjacent Defendant’s territory. However, many of the Blues have entered into what they call “gentlemen’s agreements” not to compete in those counties. For example, HCSC refused to enter into contracts with facilities in St. Louis, Missouri because it and WellPoint had agreed not to compete in each other’s Service Areas, despite being allowed to do so by the Licensing Agreements.
Provider complaint allegation, In re Blue Cross Blue Shield Antitrust Litigation, paragraph 201
The alleged agreement did work the license itself did not require. A facility could sit within reach of another Blue’s permitted contracting area and still have that alternative shut off. For a contracting employee, the reason given for declining the business can be as revealing as the territorial map.
The complaint alleged that Blue Cross of Alabama recouped the difference when another Blue paid an east Alabama hospital at a higher rate. The hospital had billed out-of-area Blues directly for care delivered to their subscribers. Blue Cross of Minnesota was among the Plans that allegedly paid its normal rates, which were higher than Alabama Blue’s rates.
According to the complaint, Alabama Blue then recovered the difference from payments due for services to its own subscribers. The hospital found a better-paying Blue. Alabama Blue allegedly took the gain back.
The complaint also quoted WellPoint’s explanation for refusing a national imaging network. In that explanation, the association’s requirements meant the local Plan had to receive and price local claims under the applicable provider agreements and make payments to local providers, including those outside its network. Routing, pricing and payment all passed through the local Plan.
For a provider, an insurance product sold somewhere else could therefore bring the local Plan’s rate back to the negotiating table.
The complaint alleged that the University of Pittsburgh Medical Center sought separate contracts with Blues around the country during a dispute with Highmark, only to receive refusals that the association helped coordinate. Some Plans, including Blue Cross of Alabama and Anthem Blue Cross of New Hampshire, allegedly refused directly. The association communicated refusals for other Plans.
The complaint described another attempted alternative. Capital Blue Cross, through Avalon, tried to offer Blue subscribers a way to obtain in-network treatment at the medical center. Highmark objected, and the association allegedly prohibited the arrangement.
These allegations show the association and the Plans doing different things within the same dispute. Highmark had the local contracting conflict. Another Plan tried to offer a route to in-network care. The association allegedly stopped it. To a provider looking for another purchaser of its services, the commercial question was whether another Blue could actually make an independent offer.
The complaint’s examples also explain why a refusal matters beyond the final rate. The alleged restriction could prevent the negotiation from happening at all. A contract never offered leaves a different trail from a negotiated contract with an unfavorable price: the request, the response and the decision about who was allowed to say yes.
The provider complaint alleged an information imbalance as well as territorial restrictions. It said that Plans, including CareFirst, required providers to disclose what other health insurers paid them while refusing to disclose what those Plans paid other providers.
That alleged arrangement gave the insurer a view of the provider’s competing offers without giving the provider the corresponding view of the insurer’s other deals. The complaint said it advantaged the Plans in bargaining. It also alleged that a consortium used nationwide claims data to support deeper discounts on provider reimbursements.
The pressure allegedly continued when providers tried to work outside the network. The complaint described efforts to force out-of-network providers into contracts at below-market rates. It also alleged threats to remove providers from Blue networks when they believed their patients were better served at an out-of-network facility.
Subscribers challenged restrictions affecting their purchase of coverage. Providers challenged restrictions affecting what they were paid for care. A subscriber buys the health benefit. A provider supplies the service the Plan pays for. The alleged limits on competition operated on opposite sides of that exchange.
For subscribers, the case concerned competition among the Plans selling the product. The provider examples concern a different lost opportunity: a hospital seeking another contracting partner, an out-of-area Plan paying more, or a provider trying to obtain better terms outside the network.
The settlements reflect that separation. They arose within the same federal litigation in Alabama, but the subscriber class and provider class had separate funds. The provider settlement’s compensation addressed alleged provider-price fixing and territorial allocation. The subscriber settlement addressed the purchasers’ claims about competition among Plans.
The subscriber settlement combined a fund with changes to business practices. The federal court granted final approval on August 9, 2022.
For providers, the court-authorized administrator reports final approval on August 19, 2025, and an effective date of September 19, 2025. The provider settlement resolved its own territorial-allocation and provider-price-fixing allegations.
An insider can connect a territorial restriction to the decision that implemented it. In these allegations, that connection appears in refusals to contract, association communications, revenue requirements, claims-routing instructions and recouped payments. Someone who handled those decisions may know why the business acted as it did.
The 2018 construction-bidding review distinguishes indirect statistical evidence from direct insider evidence, a distinction useful here because a pattern of low reimbursement and a communication explaining why another Plan refused to negotiate tell different parts of the story.
Our work with an insider starts with that connection. We examine how the agreement, the people carrying it out and the financial effect fit together, then bring in whistleblower lawyers with the relevant antitrust or healthcare fraud experience.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. Where an insider’s evidence also concerns false claims for government payment, our experts assess that conduct with the competition allegations. The payment records and what was represented to the government matter to that assessment.
Our whistleblower experts assess the reporting and reward options with you. If you know who directed a refusal to compete or how a disputed payment rule was enforced, that inside account is where we start.
If you handled territorial restrictions, coordinated contract refusals or provider payments, talk with our whistleblower experts about the decisions you saw. We build your strongest case with you, find whistleblower lawyers who understand insurer competition and health care payments, and stay beside you through the pursuit of a recovery.